12:00 AM
Feb 16, 2009
 |  BC Week In Review  |  Company News  |  Deals

Ligand, Trevena, Schering-Plough deal

Ligand will screen its combinatorial library against 24 targets provided by Trevena to identify compounds targeting GPCRs. Trevena will have exclusive, worldwide rights to sublicense any resulting compounds and is responsible...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >